We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

kindr currently serves patients in the United States only. Content is for informational purposes elsewhere.

Sexual health · Hormones

Low libido in menopause: hormones, testosterone, and what actually works

Desire that used to be reflexive is now absent. Arousal is slower. Orgasm harder. This isn't 'just getting older' — it's a treatable combination of estrogen loss, testosterone decline, pain from GSM, sleep debt, and relationship context. Testosterone therapy in particular is the most evidence-backed, most under-prescribed intervention for female desire disorder.

The multi-factor picture

  • Estrogen loss → vaginal dryness, painful sex, dampened response.
  • Testosterone decline → reduced desire, reduced clitoral sensitivity.
  • Sleep debt → cortisol up, testosterone down, energy for sex zero.
  • Mood/anxiety → SSRIs blunt orgasm; anxiety kills spontaneous desire.
  • Relationship context — often the biggest single factor.

The treatment stack

  1. Fix the mechanics first — vaginal estrogen for dryness/pain. This alone often restores desire.
  2. Systemic HRT — stabilizes mood, sleep, and energy.
  3. Transdermal testosterone — 1/10th male dose, target premenopausal free testosterone levels.
  4. Address SSRIs — consider switching to bupropion or adding it if antidepressant-driven.
  5. Sleep, strength training, relationship work.

The testosterone data

The APHRODITE trials (transdermal testosterone patch) showed significant improvement in desire and satisfying sexual events in surgically and naturally menopausal women. The Global Consensus Position Statement (Davis et al., 2019) endorses testosterone for HSDD in postmenopausal women. The problem is regulatory — no FDA-approved female product exists in the US, so prescribing is off-label.

What Kindr does

Our clinicians evaluate the multi-factor picture, treat GSM first, and prescribe systemic HRT ± testosterone when clinically indicated. Same-week telehealth in all 50 states.

Frequently asked questions

Does menopause cause low libido?

Yes, through multiple mechanisms — estrogen loss (dryness, painful sex), testosterone decline (reduced desire), sleep disruption, and mood changes. Most women experience some degree of libido change.

Does testosterone work for female libido?

Yes. Meta-analyses of transdermal testosterone in postmenopausal women show significant improvement in desire, arousal, and satisfying sexual events. The Global Consensus Position Statement (2019) endorses its use for HSDD.

Is testosterone safe for women?

At physiologic doses (bringing levels into premenopausal range), yes. Side effects are dose-dependent and reversible: acne, hair growth. Supraphysiologic doses can cause voice change.

Can I get testosterone in the US as a woman?

No FDA-approved testosterone product exists for women in the US. Clinicians prescribe compounded testosterone or off-label micro-dosing of male-approved products. Kindr can prescribe when clinically indicated.

What about flibanserin and bremelanotide?

FDA-approved for HSDD in premenopausal women. Off-label use in postmenopausal is possible but response rates are modest. Not first-line for menopause-related desire loss.

Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.

Request your Longevity Consult →

Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service

Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.

Ask Dot